✦ LIBER ✦

Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia

✍ Scribed by Jérôme Doyen; Antoine Italiano; Frédéric Peyrade; Claude Bouyer; Antoine Thyss

Book ID: 108675711
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 55 KB
Volume: 141
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2008.07096.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decitabine combined with fractionated ge

Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia

✍ Saeeda Chowdhury; Stuart Seropian; Peter W. Marks 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Gemtuzumab ozogamicin, fludarabine, cyta

Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia

✍ Apostolia Tsimberidou; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Sr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Gemtuzumab ozogamicin as maintenance the

Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia

✍ Nicola Cascavilla; Giovanni D’Arena; Michele Mario Greco; Lorella Melillo; Emanu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Low-dose Gemtuzumab-Ozogamicin as post-c

Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study

✍ Antonella Poloni; Debora Capelli; Silvia Trappolini; Benedetta Costantini; Mauro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Salvage treatment for children with refr

Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study

✍ Christian M. Zwaan; Dirk Reinhardt; Martin Zimmerman; Henrik Hasle; Jan Stary; B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Mitoxantrone, etoposide, and cytarabine

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia : An Eastern Cooperative Oncology Group pilot study

✍ Martin S. Tallman; Sandra Lee; Branimir I. Sikic; Elisabeth Paietta; Peter H. Wi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: One potential mechanism of drug resistance to chemotherapy is the overexpression of multidrug resistance (mdr) genes coding for p-glycoprotein (p-gp), which leads to reduced intracellular retention of chemotherapy. this study tested the efficacy and toxicity of mitoxantrone, etoposid